Schlegel; Mark K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schlegel; Mark K..The latest application filed is for "modified rna agents with reduced off-target effect".

Company Profile

4.6.14

Schlegel; Mark K. - Boston MA
SCHLEGEL; Mark K. - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Angiopoietin-like 3 (angptl3) Irna Compositions And Methods Of Use Thereof App 20220290153 - BonDurant; Lucas D. ; et al.	2022-09-15
Modified RNA Agents with Reduced Off-Target Effect App 20220290145 - MATSUDA; Shigeo ; et al.	2022-09-15
Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof Grant 11,326,166 - McIninch , et al. May 10, 2	2022-05-10
Coronavirus Irna Compositions And Methods Of Use Thereof App 20220127615 - Akinc; Akin ; et al.	2022-04-28
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20220042014 - Tremblay; Frederic ; et al.	2022-02-10
Coronavirus iRNA compositions and methods of use thereof Grant 11,208,660 - Akinc , et al. December 28, 2	2021-12-28
Modified Double Stranded Oligonucleotide App 20210388356 - FOSTER; Donald ; et al.	2021-12-16
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof Grant 11,162,103 - Tremblay , et al. November 2, 2	2021-11-02
HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF App 20210332365 - JADHAV; Vasant R. ; et al.	2021-10-28
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof Grant 11,149,276 - Tremblay , et al. October 19, 2	2021-10-19
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20210310006 - Foster; Donald ; et al.	2021-10-07
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20210292756 - Tremblay; Frederic ; et al.	2021-09-23
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20210269796 - Schlegel; Mark K. ; et al.	2021-09-02
Modified Rna Agents With Reduced Off-target Effect App 20210238595 - MATSUDA; Shigeo ; et al.	2021-08-05
Chirally-enriched Double-stranded Rna Agents App 20210207144 - MANOHARAN; Muthiah ; et al.	2021-07-08
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20210189400 - Tremblay; Frederic ; et al.	2021-06-24
Angiotensinogen (AGT) iRNA compositions and methods of use thereof Grant 11,015,201 - Foster , et al. May 25, 2	2021-05-25
Serpina1 iRNA compositions and methods of use thereof Grant 10,995,336 - Schlegel , et al. May 4, 2	2021-05-04
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20210095290 - Foster; Donald ; et al.	2021-04-01
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20190316127 - Schlegel; Mark K. ; et al.	2019-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.